In this engaging, highly detailed and meticulously researched account of late twentieth century technological dreaming and development, W. Patrick McCray traces the links between United States advocates of space colonies in the 1970s, and promoters of nanotechnology in the 1980s and 1990s. McCray does a compelling job of elucidating the personal, scientific and ideological ties between the groups, the substantive roles played by many individuals and institutions in both movements, and the enduring importance of past space glory in the American (...) imaginary.To write this “contemporary history”, McCray has brought together an impressive collection of archival material, including many documents from what were previously disparate personal collections and records. He has conducted interviews with many of the key actors and drawn on contemporary media reports and popular publications, the academic and grey literature.McCray’s focus is on a select group of people he dubs “visioneers”—a neo .. (shrink)

As health care systems have been recast as innovation assets, commercial aims are increasingly prominent within states’ health and medical research policies. Despite this, the reformulation of notions of social and of scientific value and of long-standing relations between science and the state that is occurring in research policies remains comparatively unexamined. Addressing this lacuna, this article investigates the articulation of ‘actually existing neoliberalism' in research policy by examining a major Australian research policy and funding instrument, the Medical Research Future (...) Fund. We identify the MRFF and allied initiatives as a site of state activism: reallocating resources from primary and preventive health care to commercially-oriented biomedical research; privileging commercial objectives in research and casting health as a “flow on effect”; reorganising the publicly funded production of health and medical knowledge; and arrogating for political actors a newly prominent role in research grant assessment and funding allocation. We conclude that rather than the state’s assumption of a more activist role in medical research and innovation straightforwardly serving a ‘public good’, it is a driver of neoliberalisation that erodes commitments to redistributive justice in health care and significantly reconfigures science-state relations in research policy. (shrink)